首页> 外国专利> PREPARATION FOR TRANS-LUNG ADMINISTRATION CONTAINING HYALURONIC ACID

PREPARATION FOR TRANS-LUNG ADMINISTRATION CONTAINING HYALURONIC ACID

机译:含透明质酸的经肺给药的制备

摘要

PROBLEM TO BE SOLVED: To obtain the subject preparation for trans-lung administration, in which peptidic drugs are formulated with hyaluronic acid and by which the absorption of the peptidic drugs, particularly insulin, into the body system is significantly increased and the drugs are stabilized. ;SOLUTION: This method for preparation is carried out by dissolving an peptidic drug (e.g. human insulin or the like) into an isotonic phosphoric acid buffer brine (pH7.0) to prepare an aqueous solution of the peptidic drug and then by dissolving sodium hyaluronate into this aqueous solution, so that the solution finally becomes in a concentration of 0.075-0.125wt.%, to form an objective preparation for trans-lung administration, by which a dosage form capable of significantly increasing absorption of the peptidic drug, particularly insulin, into the body system is given and the drug in the preparation can be stabilized.;COPYRIGHT: (C)1997,JPO
机译:要解决的问题:为了获得用于经肺给药的主题制剂,其中用透明质酸配制肽类药物,并显着增加肽类药物特别是胰岛素在人体系统中的吸收,并使药物稳定。 ;解决方案:该制备方法是通过将肽类药物(例如人胰岛素等)溶解在等渗的磷酸缓冲盐水(pH7.0)中以制备肽类药物的水溶液,然后溶解透明质酸钠来进行的。到该水溶液中,使得溶液最终达到0.075-0.125wt。%的浓度,以形成用于经肺给药的客观制剂,通过该制剂能够显着增加肽类药物特别是胰岛素的吸收,已进入人体系统,并且制剂中的药物可以稳定。;版权:(C)1997,JPO

著录项

  • 公开/公告号JPH09309843A

    专利类型

  • 公开/公告日1997-12-02

    原文格式PDF

  • 申请/专利权人 SHISEIDO CO LTD;

    申请/专利号JP19960148471

  • 申请日1996-05-21

  • 分类号A61K38/00;A61K9/08;A61K9/72;A61K38/28;A61K38/23;A61K47/36;

  • 国家 JP

  • 入库时间 2022-08-22 03:03:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号